Price Target Update on Boston Scientific Corporation (NYSE:BSX)

Boston Scientific Corporation (NYSE:BSX) : 19 Wall Street analysts covering Boston Scientific Corporation (NYSE:BSX) believe that the average level the stock could reach for the short term is $23.95. The maximum price target given is $28 and the minimum target for short term is around $20, hence the standard deviation is calculated at $2.27.

Other Equity analysts have also commented on the company shares. Guggenheim Securities initiates coverage on Boston Scientific Corporation (NYSE:BSX). The rating major has initiated the coverage with buy rating on the shares. The rating by the firm was issued on June 9, 2016.

Boston Scientific Corporation (NYSE:BSX): stock turned positive on Thursday. Though the stock opened at $22.91, the bulls momentum made the stock top out at $22.97 level for the day. The stock recorded a low of $22.84 and closed the trading day at $22.97, in the green by 1.37%. The total traded volume for the day was 11,494,915. The stock had closed at $22.66 in the previous days trading.

The company shares have rallied 24.30% from its 1 Year high price. On Jun 9, 2016, the shares registered one year high at $23.35 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $22.53 and the 200 Day Moving Average price is recorded at $19.37. On the companys insider trading activities, The officer (EVP, GC & Chief Admin Officer), of Boston Scientific Corp, Pratt Timothy A. had unloaded 24,229 shares at $22.66 per share in a transaction on June 1, 2016. The total value of transaction was $549,029. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.